Preventing adverse remodeling and rupture during healing after myocardial infarction in mice and humans.
Jugdutt
Bodh I
BI
D000818:Animals; D050822:Cytokine Receptor gp130 / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation / Q000235:genetics; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000235:genetics; D051379:Mice; D008817:Mice, Mutant Strains; D020125:Mutation, Missense; D009203:Myocardial Infarction / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D009205:Myocarditis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000473:pathology; D012422:Rupture, Spontaneous / Q000235:genetics / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D020257:Ventricular Remodeling
C508600:IL6 protein, human; C494199:IL6ST protein, human; C494200:Il6st protein, mouse; D015850:Interleukin-6; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C494087:Stat3 protein, mouse; D050822:Cytokine Receptor gp130